Nothing Special   »   [go: up one dir, main page]

Bello et al., 2011 - Google Patents

Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors

Bello et al., 2011

View HTML
Document ID
12509464470465111319
Author
Bello E
Mateo Y
Gelman D
Noaín D
Shin J
Low M
Alvarez V
Lovinger D
Rubinstein M
Publication year
Publication venue
Nature neuroscience

External Links

Snippet

Dopamine (DA) D2 receptors expressed in DA neurons (D2 autoreceptors) exert a negative feedback regulation that reduces DA neuron firing, DA synthesis and DA release. As D2 receptors are mostly expressed in postsynaptic neurons, pharmacological and genetic …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Similar Documents

Publication Publication Date Title
Bello et al. Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors
Unger et al. Directed evolution of a selective and sensitive serotonin sensor via machine learning
Woo et al. Piezo2 is the principal mechanotransduction channel for proprioception
Deng et al. MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants
Parker et al. Reward and choice encoding in terminals of midbrain dopamine neurons depends on striatal target
Selcho et al. The role of dopamine in Drosophila larval classical olfactory conditioning
Gizowski et al. Clock-driven vasopressin neurotransmission mediates anticipatory thirst prior to sleep
Calipari et al. Dopaminergic dynamics underlying sex-specific cocaine reward
Day et al. Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens
Busto et al. Olfactory learning in Drosophila
Cui et al. Increased NR2A: NR2B ratio compresses long-term depression range and constrains long-term memory
Brembs et al. Flight initiation and maintenance deficits in flies with genetically altered biogenic amine levels
Kim et al. Optogenetic mimicry of the transient activation of dopamine neurons by natural reward is sufficient for operant reinforcement
Roitman et al. Dopamine operates as a subsecond modulator of food seeking
Mahrt et al. Engineered deafness reveals that mouse courtship vocalizations do not require auditory experience
Wetzel et al. Small-molecule inhibition of STOML3 oligomerization reverses pathological mechanical hypersensitivity
Gosgnach et al. V1 spinal neurons regulate the speed of vertebrate locomotor outputs
Besson et al. Cocaine modulation of frontostriatal expression of Zif268, D2, and 5-HT2c receptors in high and low impulsive rats
Wanat et al. Delays conferred by escalating costs modulate dopamine release to rewards but not their predictors
Jentsch et al. Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice
Djamshidian et al. Novelty seeking behaviour in Parkinson's disease
George et al. Enhanced heroin self-administration and distinct dopamine adaptations in female rats
Eddine et al. A concurrent excitation and inhibition of dopaminergic subpopulations in response to nicotine
Hernandez et al. Selective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons
Quraishi et al. Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (KNa1. 1) Na+-activated K+ channels